Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs

Heterocycles containing the pyranopyrimidine motif have attracted the interest of researchers in recent decades due to their ability to synthesize and explore at a large scale to explore the biological diversity. Therefore, this review highlights the biological characteristics and synthetic approach...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MedChemComm 2022-05, Vol.13 (5), p.522-567
Hauptverfasser: Elattar, Khaled M, El-Khateeb, Ayman Y, Hamed, Sahar E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 567
container_issue 5
container_start_page 522
container_title MedChemComm
container_volume 13
creator Elattar, Khaled M
El-Khateeb, Ayman Y
Hamed, Sahar E
description Heterocycles containing the pyranopyrimidine motif have attracted the interest of researchers in recent decades due to their ability to synthesize and explore at a large scale to explore the biological diversity. Therefore, this review highlights the biological characteristics and synthetic approaches adopted to prepare pyranopyrimidine analogs in the last five years. Several novel preparation procedures have been summarized to synthesize these compounds using ionic, basic, or nanocatalysts or catalyst-free conditions to obtain these compounds in good yields. Pyranopyrimidines could also be used as ligands in the preparation of metal complexes with increased biological potency. The different sections include the antimicrobial, antitubercular, antimalarial, antiviral "SARS-CoV-2 inhibitors", antidiabetic, antitumor, cytotoxic, antiinflammatory, antioxidant, anticoagulant, urease inhibitory activities, and tyrosine inhibitors. The results are discussed based on the structure-activity relationships (SARs) and the mechanism of action. The current review highlights the importance of pyranopyrimidines as privileged biologically active molecules. It also discusses recent synthetic strategies for the synthesis of these compounds, the mechanism of action, and SARs.
doi_str_mv 10.1039/d2md00076h
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2675982274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2675982274</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-94b084604b4c35ffbf35f427ace21db9be84465286c66c00dbc2820d3d29241a3</originalsourceid><addsrcrecordid>eNpdkUtLAzEUhYMoWmo37pUBNyJUMzeZTLIRpPUFihsFdyGTyXRSppOaTIX-e9NW62NzE-75OJzLQegoxRcpJuKyhFmJMc5ZvYN6wAgMOeOw--t_gAYhTCMDWZqyTOyjA5IxQRkXPfT20AY7qbuQ2LZzSVebxBtt2i6ZezfxJqyE9XpmSqttq5pE12ZmQ-eXiauS-dKr1sVpZ7a0rUlURNwkHKK9SjXBDL7ePnq9vXkZ3Q8fn-8eRtePQ02Bd0NBC8wpw7SgmmRVVVRxUsiVNpCWhSgMp5RlwJlmTGNcFho44JKUIICmivTR1cZ3vihixFV0rxo5j3mUX0qnrPyrtLaWE_chRUpITnA0OPsy8O59YUIn43HaNI1qjVsECSzPBAfIaURP_6FTt_Dx3hXFBMYcGETqfENp70LwptqGSbFcdSbH8DRed3Yf4ZPf8bfod0MRON4APuit-lM6-QTM4Jyo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2669008262</pqid></control><display><type>article</type><title>Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs</title><source>Royal Society Of Chemistry Journals 2008-</source><source>PubMed Central</source><creator>Elattar, Khaled M ; El-Khateeb, Ayman Y ; Hamed, Sahar E</creator><creatorcontrib>Elattar, Khaled M ; El-Khateeb, Ayman Y ; Hamed, Sahar E</creatorcontrib><description>Heterocycles containing the pyranopyrimidine motif have attracted the interest of researchers in recent decades due to their ability to synthesize and explore at a large scale to explore the biological diversity. Therefore, this review highlights the biological characteristics and synthetic approaches adopted to prepare pyranopyrimidine analogs in the last five years. Several novel preparation procedures have been summarized to synthesize these compounds using ionic, basic, or nanocatalysts or catalyst-free conditions to obtain these compounds in good yields. Pyranopyrimidines could also be used as ligands in the preparation of metal complexes with increased biological potency. The different sections include the antimicrobial, antitubercular, antimalarial, antiviral "SARS-CoV-2 inhibitors", antidiabetic, antitumor, cytotoxic, antiinflammatory, antioxidant, anticoagulant, urease inhibitory activities, and tyrosine inhibitors. The results are discussed based on the structure-activity relationships (SARs) and the mechanism of action. The current review highlights the importance of pyranopyrimidines as privileged biologically active molecules. It also discusses recent synthetic strategies for the synthesis of these compounds, the mechanism of action, and SARs.</description><identifier>ISSN: 2632-8682</identifier><identifier>ISSN: 2040-2503</identifier><identifier>EISSN: 2632-8682</identifier><identifier>EISSN: 2040-2511</identifier><identifier>DOI: 10.1039/d2md00076h</identifier><identifier>PMID: 35694689</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Analogs ; Antiinfectives and antibacterials ; Antimalarial agents ; Antioxidants ; Biodiversity ; Catalysts ; Chemistry ; Coordination compounds ; Cytotoxicity ; Diabetes mellitus ; Inhibitors ; Metal complexes ; Severe acute respiratory syndrome coronavirus 2 ; Tyrosine ; Urease</subject><ispartof>MedChemComm, 2022-05, Vol.13 (5), p.522-567</ispartof><rights>This journal is © The Royal Society of Chemistry.</rights><rights>Copyright Royal Society of Chemistry 2022</rights><rights>This journal is © The Royal Society of Chemistry 2022 RSC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-94b084604b4c35ffbf35f427ace21db9be84465286c66c00dbc2820d3d29241a3</citedby><cites>FETCH-LOGICAL-c428t-94b084604b4c35ffbf35f427ace21db9be84465286c66c00dbc2820d3d29241a3</cites><orcidid>0000-0003-4014-524X ; 0000-0002-3426-3373</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133730/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133730/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35694689$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elattar, Khaled M</creatorcontrib><creatorcontrib>El-Khateeb, Ayman Y</creatorcontrib><creatorcontrib>Hamed, Sahar E</creatorcontrib><title>Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs</title><title>MedChemComm</title><addtitle>RSC Med Chem</addtitle><description>Heterocycles containing the pyranopyrimidine motif have attracted the interest of researchers in recent decades due to their ability to synthesize and explore at a large scale to explore the biological diversity. Therefore, this review highlights the biological characteristics and synthetic approaches adopted to prepare pyranopyrimidine analogs in the last five years. Several novel preparation procedures have been summarized to synthesize these compounds using ionic, basic, or nanocatalysts or catalyst-free conditions to obtain these compounds in good yields. Pyranopyrimidines could also be used as ligands in the preparation of metal complexes with increased biological potency. The different sections include the antimicrobial, antitubercular, antimalarial, antiviral "SARS-CoV-2 inhibitors", antidiabetic, antitumor, cytotoxic, antiinflammatory, antioxidant, anticoagulant, urease inhibitory activities, and tyrosine inhibitors. The results are discussed based on the structure-activity relationships (SARs) and the mechanism of action. The current review highlights the importance of pyranopyrimidines as privileged biologically active molecules. It also discusses recent synthetic strategies for the synthesis of these compounds, the mechanism of action, and SARs.</description><subject>Analogs</subject><subject>Antiinfectives and antibacterials</subject><subject>Antimalarial agents</subject><subject>Antioxidants</subject><subject>Biodiversity</subject><subject>Catalysts</subject><subject>Chemistry</subject><subject>Coordination compounds</subject><subject>Cytotoxicity</subject><subject>Diabetes mellitus</subject><subject>Inhibitors</subject><subject>Metal complexes</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Tyrosine</subject><subject>Urease</subject><issn>2632-8682</issn><issn>2040-2503</issn><issn>2632-8682</issn><issn>2040-2511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkUtLAzEUhYMoWmo37pUBNyJUMzeZTLIRpPUFihsFdyGTyXRSppOaTIX-e9NW62NzE-75OJzLQegoxRcpJuKyhFmJMc5ZvYN6wAgMOeOw--t_gAYhTCMDWZqyTOyjA5IxQRkXPfT20AY7qbuQ2LZzSVebxBtt2i6ZezfxJqyE9XpmSqttq5pE12ZmQ-eXiauS-dKr1sVpZ7a0rUlURNwkHKK9SjXBDL7ePnq9vXkZ3Q8fn-8eRtePQ02Bd0NBC8wpw7SgmmRVVVRxUsiVNpCWhSgMp5RlwJlmTGNcFho44JKUIICmivTR1cZ3vihixFV0rxo5j3mUX0qnrPyrtLaWE_chRUpITnA0OPsy8O59YUIn43HaNI1qjVsECSzPBAfIaURP_6FTt_Dx3hXFBMYcGETqfENp70LwptqGSbFcdSbH8DRed3Yf4ZPf8bfod0MRON4APuit-lM6-QTM4Jyo</recordid><startdate>20220525</startdate><enddate>20220525</enddate><creator>Elattar, Khaled M</creator><creator>El-Khateeb, Ayman Y</creator><creator>Hamed, Sahar E</creator><general>Royal Society of Chemistry</general><general>RSC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T5</scope><scope>7T7</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4014-524X</orcidid><orcidid>https://orcid.org/0000-0002-3426-3373</orcidid></search><sort><creationdate>20220525</creationdate><title>Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs</title><author>Elattar, Khaled M ; El-Khateeb, Ayman Y ; Hamed, Sahar E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-94b084604b4c35ffbf35f427ace21db9be84465286c66c00dbc2820d3d29241a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analogs</topic><topic>Antiinfectives and antibacterials</topic><topic>Antimalarial agents</topic><topic>Antioxidants</topic><topic>Biodiversity</topic><topic>Catalysts</topic><topic>Chemistry</topic><topic>Coordination compounds</topic><topic>Cytotoxicity</topic><topic>Diabetes mellitus</topic><topic>Inhibitors</topic><topic>Metal complexes</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Tyrosine</topic><topic>Urease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elattar, Khaled M</creatorcontrib><creatorcontrib>El-Khateeb, Ayman Y</creatorcontrib><creatorcontrib>Hamed, Sahar E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>MedChemComm</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elattar, Khaled M</au><au>El-Khateeb, Ayman Y</au><au>Hamed, Sahar E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs</atitle><jtitle>MedChemComm</jtitle><addtitle>RSC Med Chem</addtitle><date>2022-05-25</date><risdate>2022</risdate><volume>13</volume><issue>5</issue><spage>522</spage><epage>567</epage><pages>522-567</pages><issn>2632-8682</issn><issn>2040-2503</issn><eissn>2632-8682</eissn><eissn>2040-2511</eissn><abstract>Heterocycles containing the pyranopyrimidine motif have attracted the interest of researchers in recent decades due to their ability to synthesize and explore at a large scale to explore the biological diversity. Therefore, this review highlights the biological characteristics and synthetic approaches adopted to prepare pyranopyrimidine analogs in the last five years. Several novel preparation procedures have been summarized to synthesize these compounds using ionic, basic, or nanocatalysts or catalyst-free conditions to obtain these compounds in good yields. Pyranopyrimidines could also be used as ligands in the preparation of metal complexes with increased biological potency. The different sections include the antimicrobial, antitubercular, antimalarial, antiviral "SARS-CoV-2 inhibitors", antidiabetic, antitumor, cytotoxic, antiinflammatory, antioxidant, anticoagulant, urease inhibitory activities, and tyrosine inhibitors. The results are discussed based on the structure-activity relationships (SARs) and the mechanism of action. The current review highlights the importance of pyranopyrimidines as privileged biologically active molecules. It also discusses recent synthetic strategies for the synthesis of these compounds, the mechanism of action, and SARs.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>35694689</pmid><doi>10.1039/d2md00076h</doi><tpages>46</tpages><orcidid>https://orcid.org/0000-0003-4014-524X</orcidid><orcidid>https://orcid.org/0000-0002-3426-3373</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2632-8682
ispartof MedChemComm, 2022-05, Vol.13 (5), p.522-567
issn 2632-8682
2040-2503
2632-8682
2040-2511
language eng
recordid cdi_proquest_miscellaneous_2675982274
source Royal Society Of Chemistry Journals 2008-; PubMed Central
subjects Analogs
Antiinfectives and antibacterials
Antimalarial agents
Antioxidants
Biodiversity
Catalysts
Chemistry
Coordination compounds
Cytotoxicity
Diabetes mellitus
Inhibitors
Metal complexes
Severe acute respiratory syndrome coronavirus 2
Tyrosine
Urease
title Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T05%3A08%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insights%20into%20the%20recent%20progress%20in%20the%20medicinal%20chemistry%20of%20pyranopyrimidine%20analogs&rft.jtitle=MedChemComm&rft.au=Elattar,%20Khaled%20M&rft.date=2022-05-25&rft.volume=13&rft.issue=5&rft.spage=522&rft.epage=567&rft.pages=522-567&rft.issn=2632-8682&rft.eissn=2632-8682&rft_id=info:doi/10.1039/d2md00076h&rft_dat=%3Cproquest_pubme%3E2675982274%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2669008262&rft_id=info:pmid/35694689&rfr_iscdi=true